圣克拉拉，加利福尼亞州（2017年2月8日）—飛翔科技，一家美國加州為生命科學過程管理提供測量及控制解決方案產品的生產商，正式對外宣布將在今年舉辦第四屆CellWorld上海論壇，這將是個專門為生物工藝領域創新者、遠見人士、資深決策者打造的盛大活動。

一天的會議將以邀請的形式在2017年6月13日在上海陸家嘴金融貿易區湯臣洲際大酒店舉行。今年論壇主題將是“亞洲連續生物工藝”，飛翔科技舉辦這次論壇旨在為生物制藥業領袖搭建一個高端的交流平臺共同探討亞洲連續生物工藝的應用前景及分享他們寶貴經驗。

來自亞洲和美國的受邀發言人將對變革中亞洲生物制藥的產業格局、行業發展趨勢、設備的優化做深入解讀及探討，并分享他們在連續生產領域的相關案例。同時，飛翔科技將在論壇中向大家介紹上下游單次使用工藝的創新解決方案，并分享如何運用先進的測量及自動化技術來實現連續生產。

飛翔科技總裁Barbara Paldus博士說“回顧以往幾屆CellWorld論壇，在會后我們得到大量客戶的積極評價，這讓我們感到非常高興今年能在上海舉辦第四屆論壇?！彼痔岬健拔覀兊哪繕耸菫閬喼奚镝t藥行業領袖搭建高端交流平臺，共同探討產業發展趨勢、生產設備的創新和技術發展，同時和大家一起探索智能化工具如何幫到大家適應連續生產工藝的發展趨勢?！?/P>

關于飛翔科技

總部設立在加州的飛翔科技是一家得到業界公認和好評的為單次使用上游生物工藝提供工藝放大及整體解決方案的公司。飛翔科技產品平臺包括創新一次性傳感器、模塊自動化硬件產品、智能化軟件，這些產品能讓工業過程大數據和全球化的生物制藥技術轉移更和諧。同時飛翔科技也提供全面的服務，包括設備調試和驗證以確保一次性工藝設備快速安裝和穩定運行。更多資訊，請訪問www.finesse.com。

媒體聯絡人：李鳴，86-13816082457

Finesse？ Solutions Announces CellWorld Shanghai 2017 Executive Forum

Santa Clara， California (February 8， 2017) — Finesse Solutions， Inc.， a manufacturer of measurement and control solutions for life sciences process applications， announces the fourth CellWorld Shanghai Conference， an event specifically designed for innovators， visionaries and senior executives in bioprocessing.

The one-day conference will be held by invitation only at the InterContinental Shanghai Pudong， located at Pudong’s Lujiazui Finance and Trade Zone on June 13， 2017. The theme of the event is “Continuous Bioprocessing in Asia.” Finesse intends this forum as a platform for biopharma leaders to discuss trends and share their experiences in the implementation of continuous processing in Asia.

Invited speakers from Asia and the US will discuss the changing landscape of the biopharmaceutical industry in Asia， industry trends， and how to optimise their facilities. Case studies in continuous processing will be presented. Finesse will introduce innovative solutions for both upstream and downstream single-use bioprocessing with the use of novel measurement and advanced automation for continuous processing.

“We have had overwhelming responses to our CellWorld conferences and we are excited to host this fourth CellWorld forum in Shanghai，” said Dr. Barbara Paldus， CEO of Finesse Solutions. “Our objective is to provide a platform for the leaders of Asia biopharmaceuticals producers to exchange their views on industry trends and utilization of their manufacturing facility using innovation and technology， and to explore intelligent tools that help them in adapting continuous processing.”

About Finesse Solutions， Inc.

California-based Finesse Solutions， Inc. has a proven record in providing turnkey， scalable solutions for single-use upstream bioprocessing. The Finesse product platform includes novel disposable sensors， modular automation hardware， and intelligent software that can harmonize data and technology transfer globally. Finesse also offers a complete set of services， including commissioning and validation， for the rapid and reliable deployment of single-use equipment. For more information， visit www.finesse.com.

Media： Ming Li， 86-13816082457

?